Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Statement re media speculation

28 May 2019 07:00

RNS Number : 2106A
Galliford Try PLC
28 May 2019
 

28 May 2019

 

Galliford Try plc

 

Statement regarding media speculation

 

The Board of Galliford Try plc ("Galliford Try" or the "Board") notes the recent media speculation and confirms that it received a preliminary proposal from Bovis Homes Group PLC ("Bovis Homes") to acquire Galliford Try's Linden Homes and Partnerships & Regeneration divisions in exchange for new Bovis Homes shares (the "Bovis Homes Proposal").

 

The Bovis Homes Proposal envisaged Galliford Try remaining an independent UK-listed group focussed on construction and Galliford Try shareholders receiving new Bovis Homes shares pro rata to their current Galliford Try shareholdings.

 

The Galliford Try Board carefully considered the Bovis Homes Proposal together with its financial adviser, Rothschild & Co. The Board rejected the Bovis Homes Proposal as it believes it does not fully value the Linden Homes and Partnerships & Regeneration divisions and is not in the interests of all shareholders.

 

As set out in the Trading Update on 21 May 2019, the Galliford Try Board remains confident in the long-term prospects of the group.

 

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014. The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel and Company Secretary.

 

End.

 

 

Tulchan Communications

 

James Macey White, Martin Pengelley, Elizabeth Snow

020 7353 4200

 

 

Notes to editors:

 

1. Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1bn.

 

2. N. M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting for Galliford Try and no one else in relation to the matters described in this announcement and will not be responsible to anyone other than Galliford Try for providing the protections afforded to clients of Rothschild & Co nor for providing advice in relation to the matters described in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRDMGZKLNLGLZG
Date   Source Headline
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.